Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery
University of Washington
University of Washington
Ohio State University Comprehensive Cancer Center
Stanford University
Fuda Cancer Hospital, Guangzhou
Duke University